We also tested the effects of BMS-986158 on the expression of HIV-1 co-receptors and found that BMS-986158 did not significantly affect either the CXCR4 or CCR5 receptors, indicating that BMS-986158 does not increase the risk of infection by reactivated HIV-1. Here, CXCR4 is linked to infection.